Association of E-cadherin, matrix metalloproteinases, and tissue inhibitors of metalloproteinases with the progression and metastasis of hepatocellular carcinoma

Zu-hua Gao; Maria S Tretiakova; Wen-Hua Liu; Can Gong; Peter D Farris; John Hart

doi:10.1038/modpathol.3800554

journal article Open Access Jan 01, 2006

Association of E-cadherin, matrix metalloproteinases, and tissue inhibitors of metalloproteinases with the progression and metastasis of hepatocellular carcinoma

Zu-hua Gao Maria S Tretiakova Wen-Hua Liu

Can Gong

Peter D Farris John Hart

Modern Pathology Vol. 19 No. 4 pp. 533-540 · Elsevier BV

View at Publisher Save 10.1038/modpathol.3800554

Topics

No keywords indexed for this article. Browse by subject →

References

55

[1]

Parkin "Global cancer statistics, 2002" CA Cancer J Clin (2005)

[2]

Niu "Serum vascular endothelial growth factor is a potential biomarker of metastatic recurrence after curative resection of Hepatocellular carcinoma" World J Gastroenterol (2000)

[3]

Akalin "Why hepatocellular carcinoma cells are unlikely to metastasize: is there a role for tissue inhibitor of Metalloproteinase-1?" Med Hypotheses (2001) 10.1054/mehy.2001.1271

[4]

Olubuyide "The natural history of primary liver cell carcinoma: a study of 890 untreated adult Nigerians" Cent Afr J Med (1992)

[5]

Wijnhoven "E-cadherin–catenin cell–cell adhesion complex and human cancer" Br J Surg (2000) 10.1046/j.1365-2168.2000.01513.x

[6]

Kemler "From cadherins to catenins: cytoplasmic protein interactions and regulation of cell adhesion" Trends Genet (1993) 10.1016/0168-9525(93)90250-l

[7]

Berx "E-cadherin is a tumor/invasion suppressor gene mutated in human lobular breast cancers" EMBO J (1995) 10.1002/j.1460-2075.1995.tb00301.x

[8]

Berx "Mutations of human E-cadherin (CDH1) gene" Hum Mutat (1998) 10.1002/(sici)1098-1004(1998)12:4<226::aid-humu2>3.0.co;2-d

[9]

Inayoshi "Gross appearance of hepatocellular carcinoma reflects E-cadherin expression and risk of early recurrence after surgical treatment" J Gastroenterol Hepatol (2003) 10.1046/j.1440-1746.2003.03021.x

[10]

Saeki "Correlation between metastatic potency and the down-regulation of E-cadherin in the mouse hepatoma cell lines G-1 and G-5" Oncol Rep (2000)

[11]

Shinoyama "Cadherin intercellular adhesion molecule in hepatocellular carcinomas: loss of E-cadherin in an indifferentiated carcinoma" Cancer Lett (1991) 10.1016/0304-3835(91)90206-w

[12]

Osada "E-cadherin is involved in the intrahepatic metastasis of hepatocellular carcinoma" Hepatology (1996)

[13]

Wei "Altered expression of E-cadherin in hepatocellular carcinoma: correlation with genetic alterations, β-catenin expression, and clinical features" Hepatology (2002) 10.1053/jhep.2002.35342

[14]

Endo "Immunoreactive E-cadherin, alpha-catenin, beta-catenin, and r-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters and patient survival" Hum Pathol (2000) 10.1053/hp.2000.6683

[15]

Brikedal-hansen "Matrix metalloproteinases: a review" Crit Rev Oral Biol Med (1993) 10.1177/10454411930040020401

[16]

Yoshimoto "Expression of MMP-7 (Pump-1) mRNA in human colorectal cancers" Int J Cancer (1993) 10.1002/ijc.2910540415

[17]

Senota "Relation of matrilysin messenger RNA expression with invasive activity in human gastric cancer" Clin Exp Metastasis (1998) 10.1023/a:1006509312674

[18]

Docherty "The matrix metalloproteinases and their natural inhibitors: prospects for treating degenerative tissue diseases" Trends Biotechnol (1992) 10.1016/0167-7799(92)90214-g

[19]

Matrisian "Metalloproteinases and their inhibitors in matrix remodeling" Trends Genet (1990) 10.1016/0168-9525(90)90126-q

[20]

Lichtinghagen "Expression pattern of matrix metalloproteinases in human liver" Eur J Clin Chem Clin Biochem (1995)

[21]

Kossakowska "Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis" Am J Pathol (1998) 10.1016/s0002-9440(10)65703-3

[22]

Egeblad "New functions for the matrix metalloproteinases in cancer progression" Nat Rev Cancer (2002) 10.1038/nrc745

[23]

Yang "Human macrophage metalloelastase gene expression in colorectal carcinoma and its clinicopathologic significance" Cancer (2001) 10.1002/1097-0142(20010401)91:7<1277::aid-cncr1129>3.0.co;2-h

[24]

Takeha "Stromal expression of MMP-9 and urokinase receptor is inversely associated with liver metastasis and with infiltrating growth in human colorectal cancer: a novel approach from immune/inflammatory aspect" Jpn J Cancer Res (1997) 10.1111/j.1349-7006.1997.tb00304.x

[25]

Baker "Metalloproteinase inhibitors: biological actions and therapeutic opportunities" J Cell Sci (2002) 10.1242/jcs.00063

[26]

Curry "The matrix metalloproteinase system: changes, regulation, and impact through the ovarian and uterine reproductive cycle" Endocr Rev (2003) 10.1210/er.2002-0005

[27]

Stratmann "MMP-TIMP interaction depends on residue 2 in TIMP4" FEBS Lett (2001) 10.1016/s0014-5793(01)02987-8

[28]

Hirohashi "Hepatocellular carcinoma" (2000)

[29]

Wanless "Terminology of nodular hepatocellular lesions" Hepatology (1995) 10.1002/hep.1840220341

[30]

Harris "Hepatocellular carcinogenesis: recent advances and speculations" Cancer Cells (1990)

[31]

Saito "Hepatitis C virus infection is associated with the development of hepatocellular carcinoma" Proc Natl Acad Sci USA (1990) 10.1073/pnas.87.17.6547

[32]

Chen "Elevated aflatoxin exposure and increased risk of hepatocellular carcinoma" Hepatology (1996) 10.1002/hep.510240108

[33]

Nazeako "Hepatocellular carcinoma in cirrhotic and noncirrhotic livers. A clinicohistopathologic study of 804 North American patients" Am J Clin Pathol (1996) 10.1093/ajcp/105.1.65

[34]

Kew "Hepatocellular carcinoma with and without cirrhosis. A comparison in southern African blacks" Gastroenterology (1989) 10.1016/0016-5085(89)91426-1

[35]

Okuda "Hepatocellular carcinoma without cirrhosis in Japanese patients" Gastroenterology (1989) 10.1016/0016-5085(89)91427-3

[36]

Kakar "Clinicopathologic features and survival in Fibrolamellar carcinoma: comparison with conventional hepatocellular carcinoma with and without cirrhosis" Mod Pathol (2005) 10.1038/modpathol.3800449

[37]

Gao "Predictive markers for the recurrence of hepatocellular carcinoma" J Surg Oncol (2005) 10.1002/jso.20389

[38]

Takahara "Increased expression of matrix metalloproteinases-II in experimental liver fibrosis in rats" Hepatology (1995) 10.1002/hep.1840210328

[39]

Nie "Expression of TIMP-1 and TIMP-2 in rats with hepatic fibrosis" World J Gastroenterol (2004) 10.3748/wjg.v10.i1.86

[40]

Ihara "Expression of epithelial cadherin and α- and β-Catenins in nontumoral livers and hepatocellular carcinomas" Hepatology (1996)

[41]

Matsumura "Frequent down-regulation of E-cadherin by genetic and epigenetic changes in malignant progression of hepatocellular carcinomas" Clin Cancer Res (2001)

[42]

Shimoyama "Caherin intercellular adhesion molecule in hepatocellular carcinomas: loss of E-cadherin in an undifferentiated carcinoma" Cancer Lett (1991) 10.1016/0304-3835(91)90206-w

[43]

Giannelli "Clinical role of MMP-2/TIMP-2 imbalance in hepatocellular carcinoma" Int J Cancer (2002) 10.1002/ijc.1635

[44]

Sakamoto "Overexpression of MMP-9 correlates with growth of small hepatocellular carcinoma" Int J Oncol (2000)

[45]

Arri "Overexpression of matrix metalloproteinase 9 gene in hepatocellular carcinoma with invasive potential" Hepatology (1996) 10.1002/hep.510240206

[46]

Grigioni "Evaluation of hepatocellular carcinoma aggressiveness by a panel of extracellular matrix antigens" Am J Pathol (1991)

[47]

Yamamoto "Relation of enhanced secretion of active matrix metalloproteinases with tumor spread in human hepatocellular carcinoma" Gastroenterology (1997) 10.1016/s0016-5085(97)70143-4

[48]

Ishikawa "Matrilysin is associated with progression of colorectal tumor" Cancer Lett (1996) 10.1016/0304-3835(96)04336-4

[49]

Adachi "Contribution of matrilysin (MMP-7) to the metastatic pathway of human colorectal cancers" Gut (1999) 10.1136/gut.45.2.252

[50]

Miwa "Matrix metalloproteinase-7 expression and biologic aggressiveness of cholangiocellular carcinoma" Cancer (2002) 10.1002/cncr.10235

Showing 50 of 55 references

Metrics

49

Citations

55

References

Details

Published: Jan 01, 2006
Vol/Issue: 19(4)
Pages: 533-540
License: View

Authors

State Key Discipline Laboratory of Wide bandgap Semiconductor Technology, School of Microelectronics, Xidian University, Xi’an, China

Cite This Article

Zu-hua Gao, Maria S Tretiakova, Wen-Hua Liu, et al. (2006). Association of E-cadherin, matrix metalloproteinases, and tissue inhibitors of metalloproteinases with the progression and metastasis of hepatocellular carcinoma. Modern Pathology, 19(4), 533-540. https://doi.org/10.1038/modpathol.3800554

Association of E-cadherin, matrix metalloproteinases, and tissue inhibitors of metalloproteinases with the progression and metastasis of hepatocellular carcinoma

You May Also Like